Children born to HIV-1-infected women in Sweden in 1982-2003: Trends in epidemiology and vertical transmission

Journal of Acquired Immune Deficiency Syndromes

Volumn 42, Issue 4, 2006, Pages 484-489

  Navér, Lars ^a   Lindgren, Susanne ^a   Belfrage, Erik ^a   Gyllensten, Katarina ^a   Lidman, Knut ^a   Gisslén, Magnus ^b   Ehrnst, Anneka ^a   Arneborn, Malin ^c   Bohlin, Ann Britt ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

Antenatal screening; HIV 1; Mother to child transmission; Prophylactic intervention

Indexed keywords

ANTIRETROVIRUS AGENT; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

ADULT; ARTICLE; CESAREAN SECTION; CHILD; CHILD DEATH; CONTROLLED STUDY; EPIDEMIC; EPIDEMIOLOGICAL DATA; ERADICATION THERAPY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RATE; MAJOR CLINICAL STUDY; MASS SCREENING; PERINATAL INFECTION; POPULATION RESEARCH; PREGNANT WOMAN; PRENATAL SCREENING; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SWEDEN; TREND STUDY; VERTICAL TRANSMISSION;

ADULT; DISEASE TRANSMISSION, VERTICAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; PREGNANCY; PROSPECTIVE STUDIES; SWEDEN;

EID: 33745884126     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000224571.30119.3d     Document Type: Article

References (20)

1. The Working Group on Mother-To-Child Transmission of HIV. Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: results from 13 perinatal studies. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;8(5):506-510.
2. Cooper ER, Charurat M, Mofenson L, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr. 2002;29(5):484-494.
3. European Collaborative Study. The health and social environment of uninfected infants born to HIV-infected women. AIDS Care. 2004;3:293-303.
4. Lindgren S, Bohlin AB, Forsgren M, et al. Screening for HIV-1 antibodies in pregnancy: results from the Swedish national programme. BMJ. 1993;307(6917):1447-1451.
5. European Collaborative Study. Children born to women with HIV-1 infection: natural history and risk of transmission. Lancet. 1991;337(8736):253-260.
6. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet. 1992;339(8800):1007-1012.
7. European Collaborative Study. Natural history of vertically acquired human immunodeficiency virus-1 infection. Pediatrics. 1994;94 (6 Pt 1):815-819.
8. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331(18):1173-1180.
9. The European Mode of Delivery Collaboration. Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. Lancet. 1999;353(9158):1035-1039.
10. The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 - a meta-analysis of 15 prospective cohort studies. N Engl J Med. 1999;340(13):977-987.
11. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded AIDS surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep. 1992;41(RR-17).
12. Centers for Disease Control and Prevention. 1994 revised classification system for HIV infection in children less than 13 years of age. MMWR Morb Mortal Wkly Rep. 1994;43(RR-12):1-10.
13. Nemeth A, Bygdeman S, Sandström E, et al. Early case of acquired immunodeficiency syndrome in a child from Zaire. Sex Transm Dis. 1986;13(2):111-113.
14. The Swedish Reference Group for Antiviral Therapy (RAV). Uppdaterad rekommendation for profylax och behandling vid graviditet hos HIV-1 infekterade kvinnor (In Swedish). June 08. Available at: http://www.rav.nu/, 2005.
15. Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. N Engl J Med. 1999;341(6):394-402.
16. Van Dyke RB, Korber BT, Popek E, et al. The Ariel Project: a prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy. J Infect Dis. 1999;179(2):319-328.
17. Clarke SM, Mulcahy F, Healy CM, et al. The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome. Int J STD AIDS. 2000;11(4):220-223.
18. Bardeguez AD, Shapiro DE, Mofenson LM, et al. Effect of cessation of zidovudine prophylaxis to reduce vertical transmission on maternal HIV disease progression and survival. J Acquir Immune Defic Syndr. 2003;32(2):170-181.
19. ACOG committee opinion: scheduled Cesarean delivery and the prevention of vertical transmission of HIV infection. Number 234, May 2000 (replaces number 219, August 1999). Int J Gynaecol Obstet. 2001;73(3):279-281.
20. European Collaborative Study. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy. CID. 2005;40:458-465.